Global Pharmaceutical Research

Yasuyuki Nomura

---

Yasuyuki Nomura is Professor emeritus of Hokkaido University and also Visiting Professor of Kurume University (Department of Pharmacology in School of Medicine).

He completed his graduation (1965-1970) and obtained Ph.D. (1971) in Pharmacology of Research Division in Pharmaceutical Sciences  from Kyoto University. He has served as Associated Professor, Research Associate, Professor, Dean, Professor emeritus, visiting Profesoor, Collaboratorin different departments from different universities (1972-2018).

Yasuyuki Nomura successfully organized 2^nd International Conference on Membrane Receptors, Signal Transduction and Drug Action (Sapporo, 1997). He won awards like: The Pharmaceutical Society of Japan Award for young Scientists in 1982. The Pharmaceutical Society of Japan Award (the highest award for recognition of achievement in all the  fields of Pharamaceutical Sciences) in 2001. Furthermore, he won the Encouragement Prize of Medium Enterprize Agency in 2014.

His research areas include Pathophysiological and Pharmacological Studies on Molecular and Cellular Mechanism of the Brain Functions.

Jean-Marc Sabatier

---

Jean-Marc Sabatier is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry. He is a member of 38 Editorial Boards of scientific journals, such as ‘Peptides’, ‘Molecules’ and the ‘Journal of Biological chemistry’.

He also reviewed articles submitted for publication in 74 international journals and acts as an expert for numerous institutions (ANR, CEA, CNRS, MRC, ISF, BARD, AIRD, IPT, Pasteur Institutes, Ville de Paris, Region Languedoc-Roussillon, Fondation Arthritis, etc.). He won the ‘Citizen of the Year Award’ from the Nouvel Economiste (1994) for his work on antivirals. He is a member of a dozen scientific societies, such as the ‘American Peptide Society’ (charter member), ‘European Peptide Society’, ‘American Society for Microbiology’, ‘Biochemical Society’ and ‘New-York Academy of Sciences’.

Jean-Marc Sabatier expertise in:

• Drug design and synthesis (peptides and related compounds)
• Optimization of peptide structure/conformation (to improve bioactivity, selectivity, solubility, and/or stability)
• Peptide and protein engineering
• Development of peptide-based in vitro assays (diagnostic tests, etc.)
• Toxicology
• Evaluation of research projects

Yasuyuki Nomura

---

Yasuyuki Nomura is Professor emeritus of Hokkaido University and also Visiting Professor of Kurume University (Department of Pharmacology in School of Medicine).

He completed his graduation (1965-1970) and obtained Ph.D. (1971) in Pharmacology of Research Division in Pharmaceutical Sciences  from Kyoto University. He has served as Associated Professor, Research Associate, Professor, Dean, Professor emeritus, visiting Profesoor, Collaboratorin different departments from different universities (1972-2018).

Yasuyuki Nomura successfully organized 2^nd International Conference on Membrane Receptors, Signal Transduction and Drug Action (Sapporo, 1997). He won awards like: The Pharmaceutical Society of Japan Award for young Scientists in 1982. The Pharmaceutical Society of Japan Award (the highest award for recognition of achievement in all the  fields of Pharamaceutical Sciences) in 2001. Furthermore, he won the Encouragement Prize of Medium Enterprize Agency in 2014.

His research areas include Pathophysiological and Pharmacological Studies on Molecular and Cellular Mechanism of the Brain Functions.

Jean-Marc Sabatier

---

Jean-Marc Sabatier is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry. He is a member of 38 Editorial Boards of scientific journals, such as ‘Peptides’, ‘Molecules’ and the ‘Journal of Biological chemistry’.

He also reviewed articles submitted for publication in 74 international journals and acts as an expert for numerous institutions (ANR, CEA, CNRS, MRC, ISF, BARD, AIRD, IPT, Pasteur Institutes, Ville de Paris, Region Languedoc-Roussillon, Fondation Arthritis, etc.). He won the ‘Citizen of the Year Award’ from the Nouvel Economiste (1994) for his work on antivirals. He is a member of a dozen scientific societies, such as the ‘American Peptide Society’ (charter member), ‘European Peptide Society’, ‘American Society for Microbiology’, ‘Biochemical Society’ and ‘New-York Academy of Sciences’.

Jean-Marc Sabatier expertise in:

• Drug design and synthesis (peptides and related compounds)
• Optimization of peptide structure/conformation (to improve bioactivity, selectivity, solubility, and/or stability)
• Peptide and protein engineering
• Development of peptide-based in vitro assays (diagnostic tests, etc.)
• Toxicology
• Evaluation of research projects

Regional Editor-in-Chiefs

---

Editorial Board

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

In Press

---

Current Issue

Volume 5, Issue 1

---

Archive

---

Submit Manuscript

---

Global Pharmaceutical Research welcomes direct submissions from authors: Attach your word file with e-mail and send it to: submissions@oatext.com alternatively to:  editor.gpr@oatext.com

Publication Charges

---

Global Pharmaceutical Research is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Global Pharmaceutical Research are GBP 690.

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

• Recover capitalization costs;
• Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
• Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

1. Wire/Bank transfer
2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.